U.S. Software Stock News

If you are wondering whether Federal Home Loan Mortgage at US$9.18 is still good value after its run in recent years, you are not alone. The stock has seen a 62.2% return over the last year, even though the 7 day, 30 day and year to date returns of 9.6%, 9.9% and 11.3% declines suggest some recent cooling. Recent news coverage has focused on Federal Home Loan Mortgage's role in the broader US housing finance system and the ongoing investor interest in government sponsored entities. This...

Canaan Inc. recently announced a 3.0 MW proof-of-concept with Bitforest Investment in Manitoba, where its Avalon liquid-cooled computing servers will recycle waste heat to support greenhouse operations while targeting high uptime and low power costs. This project highlights how bitcoin mining infrastructure can be repurposed as an energy-efficient heat source for agriculture, potentially broadening Canaan’s role beyond traditional mining hardware. We’ll now examine how this heat-reuse...

Why OPKO Health is on investors’ radar today OPKO Health (OPK) has drawn attention after recent trading left the share price at $1.30, with the stock showing mixed returns over the past week, month, past 3 months, and year. See our latest analysis for OPKO Health. At the current US$1.30 share price, OPKO Health’s recent 1 day and 3 month share price declines, alongside a 1 year total shareholder return loss of 11.56%, suggest that momentum has been fading, even though there has been a small...

Bank of America (BAC) FY 2025 earnings snapshot Bank of America (BAC) has wrapped up FY 2025 with fourth quarter revenue of US$27.1b and basic EPS of US$0.99, supported by trailing twelve month revenue of US$107.4b and EPS of US$3.86. The bank has seen revenue move from US$96.1b and EPS of US$3.25 on a trailing basis at the end of 2024 to US$107.4b and US$3.86 respectively, while FY 2025 net income excluding extra items came in at US$29.1b. Together with a trailing net profit margin of 27%...

Wells Fargo (WFC) just wrapped up FY 2025 with Q4 revenue of US$20.3b and basic EPS of US$1.64, anchored by quarterly net income of US$5.1b. Over the past few quarters, the bank has seen revenue move from US$19.3b in Q4 2024 to US$19.2b in Q1 2025, US$19.8b in Q2, US$20.8b in Q3 and US$20.3b in Q4. EPS tracked from US$1.45 to US$1.41, US$1.61, US$1.68 and US$1.64 over the same stretch. This sets up a year where margins and profitability sit squarely in focus for investors. See our full...

Why the latest sales update matters for Savers Value Village (SVV) Savers Value Village (SVV) has drawn fresh attention after reporting preliminary net sales for its fourth quarter and fiscal 2025, alongside an update on share repurchases and upcoming investor conference participation. See our latest analysis for Savers Value Village. The preliminary sales update and active buyback program appear to have shifted sentiment, with a 10.2% 7 day share price return and 10.9% year to date share...

If you are wondering whether Natera's current share price lines up with its underlying value, you are not alone. This article is built to help you connect the dots. Natera's stock closed at US$239.19, with returns of 4.5% year to date and about 42% over the past year. The last week showed a small 0.2% decline, the past month showed a 5.2% gain, and the three year figure is very large. Recent attention on Natera has been shaped by company specific developments and sector wide interest in...

If you are wondering whether Constellium's current share price still offers value, you are not alone. Many investors are asking the same question after its recent run. The stock last closed at US$22.77, with returns of 13.9% over 7 days, 23.9% over 30 days, 15.2% year to date and 109.9% over 1 year. This naturally raises questions about what is already priced in. Recent attention on Constellium has centered on its position as an aluminum products supplier across automotive, packaging and...

Earlier in January 2026, Monte Rosa Therapeutics completed a roughly US$300.00 million follow-on equity offering, including 11,125,000 common shares at US$24 each and 1,375,000 pre-funded warrants, shortly after releasing positive interim Phase 1 data for its NEK7-directed degrader MRT-8102 in inflammatory conditions. The Phase 1 results, showing deep NEK7 degradation alongside broad reductions in inflammatory markers such as hsCRP and IL-6 with a favorable safety profile in higher...

Concrete Pumping Holdings (BBCP) just wrapped up FY 2025 with fourth quarter revenue of US$108.8 million and basic EPS of US$0.10, alongside net income of US$4.9 million, setting the tone for how the year closed out. The company has seen quarterly revenue move from US$111.5 million and EPS of US$0.17 in Q4 FY 2024 to US$108.8 million and EPS of US$0.10 in Q4 FY 2025, while trailing twelve month net profit margins sit at 1.2% compared with 3.4% a year earlier, so investors are weighing modest...

Earlier this week, Qiagen N.V. outlined its 2026 priorities at the J.P. Morgan Healthcare Conference and the German Investment Seminar, following a special US$2.29 cash dividend with an ex-dividend date of January 8, 2026. The company underscored plans to expand its five core growth pillars, integrate the Parse Biosciences acquisition for single-cell analysis, and pursue automation, AI, and targeted M&A to reach a combined US$2.00 billion in pillar sales by 2028. We’ll now examine how...

Earlier in January 2026, Apogee Therapeutics reported positive interim Phase 1b data for its half-life extended anti-IL-13 antibody zumilokibart (APG777) in mild-to-moderate asthma, showing a favorable safety profile and strong, durable FeNO suppression after a single 720 mg dose. The update also outlined an ambitious 2026 clinical roadmap for zumilokibart and combination asset APG279 across atopic dermatitis and broader immunology indications, underscoring Apogee’s push to build a...

If you are wondering whether Brookfield Business Partners at around US$34.85 offers good value today, you are not alone. This article breaks down what that price could mean for long term investors. The unit price has moved 2.7% over the last week, while the 30 day return is a 0.9% decline and the 1 year return sits at 58.1%, with a 3 year return of 91.5% and 5 year return of 42.7%. Recent attention on Brookfield Business Partners has centered on its position as a listed arm of the wider...

Bank of New York Mellon Corporation (BK) has wrapped up FY 2025 with fourth quarter total revenue of US$5.2 billion and basic EPS of US$2.05, alongside net income of US$1.4 billion, while the trailing 12 month view shows revenue of US$20.1 billion, EPS of US$7.47 and net income of US$5.3 billion. Over recent quarters the company has seen quarterly revenue move from US$4.8 billion in Q4 2024 to US$5.0 billion in Q2 2025 and then to US$5.2 billion in Q4 2025, with quarterly basic EPS stepping...

Park Aerospace (PKE) just posted its Q3 2026 numbers, with revenue of $17.3 million and net income of $2.95 million, translating to basic EPS of $0.15. The company has seen revenue move from $16.7 million in Q2 2025 to $14.4 million in Q3 2025 and then to $17.3 million in Q3 2026, while quarterly EPS over that stretch has ranged from $0.10 to $0.15 as earnings on a trailing 12 month basis reached $8.68 million. With net profit margins on a trailing basis higher than a year ago, the latest...

Why the SOSA Energy Center Matters for Energy Vault Holdings Stock Energy Vault Holdings (NRGV) has kicked off construction of the SOSA Energy Center in Texas, a 150 MW / 300 MWh battery energy storage project that opens its Asset Vault platform and supports the company’s shift toward owning and operating infrastructure. See our latest analysis for Energy Vault Holdings. The SOSA Energy Center news comes on the heels of a US$180.6m shelf registration and a strong run in the shares, with a 90...

In early January 2026, Barrett Business Services, Inc. announced the launch of its Employee File Cabinet HRIS module within the BBSI Client Portal, a secure, centralized digital repository for employee documents developed in collaboration with Box to enhance compliance, efficiency, and access. This module underscores BBSI’s push to deepen its HR technology platform by unifying HR documents across onboarding, applicant tracking, performance management, and other core systems. Next, we’ll...

On January 12, 2026, Sotera Health used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to indicate that 2025 revenue is expected to exceed US$1.16 billion, implying at least 5.5% year-over-year growth and extending a record of more than 20 years of consecutive annual revenue increases. Management also emphasized that capital will primarily support organic expansion while selectively pursuing M&A, debt reduction, and share repurchases, underscoring a disciplined...

If you are wondering whether Titan America at US$17.25 offers good value or is already pricing in a lot of optimism, you are asking the right question and this article is built to help you frame that clearly. Over shorter timeframes the stock has moved around, with returns of 4.2% over the last 7 days, 2.1% over the last 30 days and 3.2% year to date. This may have caught your eye as either early momentum or a shift in risk perception. Recently, investors have been reacting to company...

Q.E.P (QEPC) has put another quarter on the board, with Q3 2026 revenue of US$59.1 million and basic EPS of US$1.08, while trailing 12 month EPS sits at US$4.56 on revenue of US$235.0 million and net income of US$14.8 million. Over recent quarters the company has seen revenue move between US$56.7 million and US$62.6 million and quarterly EPS range from US$1.03 to US$1.41. This gives investors a clearer view of how earnings power translates into the current 6.3% net margin. Overall, the latest...

Saul Centers (BFS) has been drawing attention after recent share performance data showed a mix of shorter term gains and longer term weakness, prompting fresh questions about how its real estate portfolio is currently being valued. See our latest analysis for Saul Centers. The recent 8.5% 90 day share price return suggests some momentum is building off the current US$32.51 level, although the 1 year total shareholder return of a 4.6% decline contrasts with the stronger 5 year total...

In January 2025, AMC Entertainment Holdings and Muvico executed a supplemental indenture with GLAS Trust Company to amend Muvico’s Senior Secured Exchangeable Notes due 2030, updating the exchange rate terms and related provisions. These changes to AMC’s financing arrangements are drawing attention because they tie operational momentum to a capital structure that still raises questions around dilution and long-term resilience. Against this backdrop of amended exchangeable notes and ongoing...

If you are wondering whether Innodata's share price still makes sense after a strong run, the key question is how its current valuation lines up with the business reality. The stock trades at US$62.70, with a 19.7% gain over the last 30 days, an 18.3% return year to date, 84.7% over the past year, and a roughly 18x gain over three years. Over the last 7 days, the share price has declined 3.6%. Recent coverage has focused on Innodata as an AI related data and services company, which ties in...

Energy Fuels stock triggered by recent performance Energy Fuels (UUUU) has come onto investors’ radar after a strong share price move, with the stock up about 49% over the past month and 10% over the past week. See our latest analysis for Energy Fuels. That recent momentum sits against a mixed backdrop, with a 30 day share price return of 49.14% and a year to date share price return of 25.36%. The 1 year total shareholder return is very large at over 3x, suggesting sentiment has shifted...